Centiva Capital’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-218,904
Closed -$2.2M 1924
2022
Q4
$2.2M Sell
218,904
-42,600
-16% -$423K 0.06% 330
2022
Q3
$2.57M Sell
261,504
-49,950
-16% -$491K 0.05% 293
2022
Q2
$3.05M Buy
311,454
+24,357
+8% +$238K 0.07% 243
2022
Q1
$2.8M Buy
+287,097
New +$2.79M 0.05% 326

Other funds holding AONC

Centiva Capital's AONC Position: Q1 2023 in Review

Centiva Capital sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 218,904 shares — an estimated $2.2M sold.

Centiva Capital first reported a position in AONC in Q1 2022 and held it in 4 quarters. The position peaked at $3.05M in Q2 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Centiva Capital reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Centiva Capital sold 218,904 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $2.2M.
  • Centiva Capital first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2022 and held it in 4 quarters.
  • Centiva Capital's American Oncology Network, Inc. Class A Common Stock position peaked at $3.05M in Q2 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Centiva Capital's 13F filing for Q1 2023, filed 15 May 2023.